Results 21 to 30 of about 1,450,283 (404)

The Alteration of Circulating Lymphocyte Subsets During Tacrolimus Therapy in Neuromyelitis Optica Spectrum Disorder and Its Correlation With Clinical Outcomes

Frontiers in Neurology, 2022
ObjectivesWe aimed to explore the alteration of circulating lymphocyte subsets before and after tacrolimus (TAC) therapy in neuromyelitis optica spectrum disorder (NMOSD) and its correlation with clinical outcomes.MethodsAnti-aquaporin-4 antibody (AQP4 ...
Liang Wang, Liang Wang, Wenjuan Huang, Wenjuan Huang, Jingzi ZhangBao, Jingzi ZhangBao, Xuechun Chang, Xuechun Chang, Hongmei Tan, Hongmei Tan, Lei Zhou, Lei Zhou, Chuanzhen Lu, Chuanzhen Lu, Min Wang, Jiahong Lu, Jiahong Lu, Chongbo Zhao, Chongbo Zhao, Chao Quan, Chao Quan   +20 more
doaj   +1 more source

A combination of the percentages of IFN-γ+CD4+T cells and granzyme B+CD19+B cells is associated with acute hepatic rejection: a case control study

Journal of Translational Medicine, 2021
Background T cells and B cells play a key role in alloimmune responses. We aimed to characterize the shift of T cell subsets and B cell subsets during acute hepatic rejection, and further determine whether they could serve as a prognostic marker. Methods
Ji-Qiao Zhu, Jing Wang, Xian-Liang Li, Wen-Li Xu, Shao-cheng Lv, Xin Zhao, Ren Lang, Qiang He   +7 more
doaj   +1 more source

The pathophysiologic significance of lymphocyte subset determination in children with infectious mononucleosis, mycoplasma pneumonia and Henoch–Schönlein purpura

BMC Pediatrics, 2022
Objective This study aimed to explore lymphocyte subset determinations as an aid to understanding the pathophysiology of infectious mononucleosis (IM), pneumonia due to mycoplasma infection (P-MI) and Henoch–Schönlein purpura in children.
Liang Zhao, Hao Wang, Hua-Xing Wei, Yong Lv   +3 more
doaj   +1 more source

High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients

Frontiers in Immunology, 2022
BackgroundCellular immunodeficiency and comorbidities are common in COVID-19 patients.AimThe purpose of this study was to investigate comorbidities impacting on the cellular immunity in COVID-19 patients.MethodsThe research objects included 55 healthy ...
Dafeng Liu, Dafeng Liu, Xiaoyan Yuan, Xiaoyan Yuan, Fengjiao Gao, Fengjiao Gao, Bennan Zhao, Bennan Zhao, Ling Ding, Ling Ding, Mingchang Huan, Mingchang Huan, Chao Liu, Chao Liu, Liangshuang Jiang, Liangshuang Jiang   +15 more
doaj   +1 more source

Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity

Virology Journal, 2022
Background Coronavirus disease 2019 (COVID-19) is a respiratory disorder caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which had rapidly spread all over the world and caused public health emergencies in the past two years ...
Wei Dai, Aifang Zhong, Qinghua Qiao, Jian Wu, Weiwei Li, Qiuyue Wu, Hongjian Zhou, Shijie Qin, Weijun Jiang, Jing Zhang, Xinyi Xia   +10 more
doaj   +1 more source

Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)

medRxiv, 2020
Background: To explore the cellular immunity and cytokines status of NCP patients and to predict the correlation between the cellular immunity levels, cytokines and the severity of patients.
S. Wan, Q. Yi, S. Fan, Jinglong Lv, Xian-xiang Zhang, Lian Guo, Chunhui Lang, Qing Xiao, Kaihu Xiao, Z. Yi, Mao Qiang, Jiang-lin Xiang, Bangshuo Zhang, Yongping Chen   +13 more
semanticscholar   +1 more source

Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients

British Journal of Haematology, 2020
We explored the relationships between lymphocyte subsets, cytokines, pulmonary inflammation index (PII) and disease evolution in patients with (corona virus disease 2019) COVID‐19.
S. Wan, Q. Yi, S. Fan, Jinglong Lv, Xian-xiang Zhang, Lian Guo, Chunhui Lang, Qing Xiao, Kaihu Xiao, Z. Yi, Mao Qiang, Jiang-lin Xiang, Bangshuo Zhang, Yongping Chen, Cailiang Gao   +14 more
semanticscholar   +1 more source

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer

Frontiers in Immunology, 2020
Immune checkpoint blockade represents a major breakthrough in advanced non-small cell lung cancer (NSCLC) therapy. However, success is limited to a subset of patients and there is a critical need to identify robust biomarkers associated with clinical ...
S. Ottonello, C. Genova, I. Cossu, V. Fontana, E. Rijavec, G. Rossi, F. Biello, M. D. Dal Bello, M. Tagliamento, A. Alama, S. Coco, S. Boccardo, I. Vanni, G. Ferlazzo, L. Moretta, F. Grossi, M. Mingari, P. Carrega, G. Pietra   +18 more
semanticscholar   +1 more source

Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID‐19

Journal of Medical Virology, 2020
To investigate the inflammatory factors and lymphocyte subsets which play an important role in the course of severe coronavirus disease 2019 (COVID‐19).
Ming Ni, Fangbing Tian, Dandan Xiang, Bing Yu   +3 more
semanticscholar   +1 more source

Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study

BMC Pulmonary Medicine, 2022
Background Immune checkpoint inhibitors (ICIs) have achieved promising effects in patients with non-small cell lung cancer (NSCLC). However, not all patients with NSCLC benefit from immunotherapy.
Yi Yan, Xinyan Wang, Chenan Liu, Junmei Jia   +3 more
doaj   +1 more source